Climb Bio Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$12.37

+0.19 (+1.56%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 19 95%

Hold 1 5%

Sell 0 0%

Price Target

Analyst Price Target +111.1% upside

Low Target $17.52

Average Target $26.11

High Target $31.20

Current Price $12.37

Current
$12.37

Target
$26.11

$17.52 $26.11 avg $31.20

Scenario Analysis

Bear Case

$17.52

41.6%

Low target

Base Case

$26.11

+111.1%

Avg target

Bull Case

$31.20

+152.2%

High target

Risk/Reward

3.7x

Highly favorable

Price in Context

52-Week High

$12.48

-0.9% from high

52-Week Low

$1.16

+966.4% from low

Target vs 52W High

$26.11

+109.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.0%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.5%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-39.1%